Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495

Reference

Title : An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials - Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495
Author(s) : Ligueros-Saylan M , Foley JE , Schweizer A , Couturier A , Kothny W
Ref : Diabetes Obes Metab , 12 :495 , 2010
Abstract : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495
ESTHER : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495
PubMedSearch : Ligueros-Saylan_2010_Diabetes.Obes.Metab_12_495
PubMedID: 20518805

Related information

Citations formats

Ligueros-Saylan M, Foley JE, Schweizer A, Couturier A, Kothny W (2010)
An assessment of adverse effects of vildagliptin versus comparators on the liver, the pancreas, the immune system, the skin and in patients with impaired renal function from a large pooled database of Phase II and III clinical trials
Diabetes Obes Metab 12 :495

Ligueros-Saylan M, Foley JE, Schweizer A, Couturier A, Kothny W (2010)
Diabetes Obes Metab 12 :495